home / stock / vtgn / vtgn news


VTGN News and Press, VistaGen Therapeutics Inc. From 04/25/21

Stock Information

Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com

Menu

VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...

VTGN - VistaGen: Phase 2 Success In Anxiety Disorder, Phase 3 To Begin

VistaGen has had a tumultuous history, but recent trials have seen success. They may start phase 3 trials for PH94B in May. Dilution is a major risk. For further details see: VistaGen: Phase 2 Success In Anxiety Disorder, Phase 3 To Begin

VTGN - VistaGen's Poster Presentation at the Anxiety and Depression Association of America's 2021 Annual Conference Differentiates PH94B's Mechanism of Action from Highly-Addictive Benzodiazepines

SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc . (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and...

VTGN - VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March

SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depressio...

VTGN - VistaGen Therapeutics files for $250M mixed shelf

VistaGen Therapeutics (VTGN) has filed a prospectus for a mixed shelf offering of up to $250M.The filing does not necessarily indicate that a sale has begun, or will occur in the future.Shares up 3.5% after-hours. Yesterday's close was $2.35. For further details see: VistaGen ...

VTGN - VistaGen's PH10 Nasal Spray Demonstrates Different Mechanism of Action from Benzodiazepines in Preclinical Study

SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc . (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anx...

VTGN - 3 Top Penny Stocks To Watch Next Week As March Begins

Could These Penny Stocks Jump Next Month? February was definitely an interesting month for penny stocks . My guess is as March begins, investors hope that it will have a much better start than how this month ended. To categorize February, we have to consider all that has happened in...

VTGN - AVGR, EBON, LODE and NXTD among midday movers

Gainers: Immunome (IMNM) +120%.Greenland Technologies (GTEC) +119%.Liberty TripAdvisor (LTRPB) +60%.Motus GI Holdings (MOTS) +35%.Charah Solutions (CHRA) +35%.Avinger (AVGR) +34%.VistaGen Therapeutics (VTGN) +32%.U.S. Well Services (USWS) +28%.Ebang International (EBON) +28%.Os...

VTGN - Immunome, Avinger leads healthcare gainers; MEDNAX, ReWalk Robotics among major losers

Gainers: Immunome (IMNM) +93%, Avinger (AVGR) +33%, Titan Pharmaceuticals (TTNP) +17%, GBS (GBS) +15%, VistaGen Therapeutics (VTGN) +15%.Losers: MEDNAX (MD) -23%, ReWalk Robotics (RWLK) -21%, Shineco (TYHT) -19%,&...

VTGN - TWLO, RIGL, ONTX and MACK among premarket gainers

Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS) +35%.Cleveland BioLabs (CB...

VTGN - VistaGen initiated with Buy at Jefferies on 'upside potential' for anxiety drug

Vistagen Therapeutics (VTGN) jumps 13% premarket after Jefferies initiated coverage with a Buy rating and price target of $6.Analyst Andrew Tsai says that company's lead asset, PH94B, a fast-acting nasal spray had compelling Phase II data and could become the first FDA-approved trea...

Previous 10 Next 10